Active cell death is a genetically encoded self-destruction of a cell.
There occur morphologically different types of active cell death, e.g
. apoptosis in the liver or autophagic cell death in human mammary car
cinoma cells after tamoxifen treatment. (Pre)neoplastic lesions in rat
liver exhibit enhanced rates of apoptosis, which tend to increase wit
h increasing malignancy. Tumor promoters and non-genotoxic carcinogens
inhibit active cell death, thereby increasing the accumulation of (pr
e)neoplastic cells and accelerating the development of cancer. On the
other hand promoter withdrawal, fasting or application of negative gro
wth signals such as transforming growth factor beta 1 (TGF beta 1) enh
ance apoptosis and can lead to selective regression of preneoplastic l
esions or tumors.